A New Oral Testosterone Undecanoate Formulation Restores Testosterone to Normal Concentrations in Hypogonadal Men

CONTEXT: A novel formulation of oral testosterone (T) undecanoate (TU) was evaluated in a phase 3 clinical trial. OBJECTIVE: Determine efficacy, short-term safety, and alignment of new oral TU formulation with current US approval standards for T replacement therapy. DESIGN: Randomized, active-contro...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Clin Endocrinol Metab
Main Authors: Swerdloff, Ronald S, Wang, Christina, White, William B, Kaminetsky, Jed, Gittelman, Marc C, Longstreth, James A, Dudley, Robert E, Danoff, Theodore M
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2020
Teme:
Clinical Research Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7282712/
https://ncbi.nlm.nih.gov/pubmed/32382745
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/clinem/dgaa238
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki